CMS certification 490063
Inova Fairfax Hospital
3300 Gallows Road, Falls Church, VA 22042
Inova Fairfax Hospital has a CMS overall rating of 5 out of 5 stars. 80% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 7 and worse on 2. Emergency patients spend a median of 2 h 41 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 877 completed surveys, 22% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | VA | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 375 visits sampled · US median for EDs of the same volume: 3 h 21 min | 2 h 41 min | 2 h 41 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 23 visits sampled | 5 h 20 min | 4 h 2 min | 4 h 17 min |
| Left before being seen Lower is better · 200,692 patients | 0% | 2% | 2% |
| Stroke symptoms: brain scan read within 45 minutes Higher is better · 26 patients | 42% | 69% | 69% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 762 patients | 81% | 67% | 65% |
How Inova Fairfax Hospital compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Inova Fairfax HospitalThis hospital | 5/5 | 80% | 2 h 41 min | 7 better 2 worse |
| Inova Fair Oaks HospitalSame county · Fairfax | 5/5 | 79% | 2 h 52 min | 4 better 1 worse |
| Fort Belvoir Community HospitalSame county · Fort Belvoir | Not rated | 89% | 2 h 37 min | — |
| Inova Mount Vernon HospitalSame county · Alexandria | 4/5 | 73% | 2 h 30 min | 2 better 1 worse |
| Reston Hospital CenterSame county · Reston | 3/5 | 64% | 2 h 12 min | 1 better 3 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Falls Church.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 8,297 cases | Too few cases | 2.6% | 3.9% |
| Heart attack 370 cases | Too few cases | 9.7% | 11.9% |
| Heart failure 1,423 cases | Too few cases | 10.1% | 11.1% |
| Pneumonia 1,212 cases | Too few cases | 12.6% | 15.2% |
| Stroke 847 cases | Too few cases | 10.9% | 11.9% |
| COPD 205 cases | Too few cases | 7.9% | 8.6% |
| Heart bypass surgery (CABG) 367 cases | Too few cases | 1.9% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 0.86 likely 0.7 – 1.02 | 1 |
| Deaths after a serious but treatable surgical complication 436 cases | No different | 149.1 per 1,000 likely 122.38 per 1,000 – 175.82 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 18,592 cases | Better | 0.08 per 1,000 likely 0 per 1,000 – 0.42 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 21,070 cases | No different | 0.14 per 1,000 likely 0 per 1,000 – 0.28 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 22,620 cases | No different | 0.24 per 1,000 likely 0.09 per 1,000 – 0.39 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 6,582 cases | No different | 2.45 per 1,000 likely 1.53 per 1,000 – 3.37 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 3,681 cases | No different | 1.78 per 1,000 likely 0.87 per 1,000 – 2.69 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 3,557 cases | No different | 7.72 per 1,000 likely 5.02 per 1,000 – 10.42 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 7,218 cases | No different | 3.55 per 1,000 likely 2.34 per 1,000 – 4.75 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 3,672 cases | No different | 7.14 per 1,000 likely 5.1 per 1,000 – 9.18 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 1,556 cases | No different | 1.7 per 1,000 likely 0.43 per 1,000 – 2.97 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 4,823 cases | No different | 1.17 per 1,000 likely 0.5 per 1,000 – 1.84 per 1,000 | 1.06 per 1,000 |
1 more measure had too few cases here to report.
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0.57 likely 0.38 – 0.84 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.56 likely 0.37 – 0.82 | 1 |
| Surgical site infections after colon surgery | No different | 0.67 likely 0.36 – 1.14 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 0.97 likely 0.53 – 1.65 | 1 |
| MRSA bloodstream infections | Better | 0.5 likely 0.26 – 0.87 | 1 |
| C. diff intestinal infections | Better | 0.49 likely 0.41 – 0.59 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 546 cases | Too few cases | 12.5% | 14.4% |
| Readmitted after heart failure 1,625 cases | Too few cases | 20.9% | 21.3% |
| Readmitted after pneumonia 1,266 cases | Too few cases | 16.9% | 17.3% |
| Readmitted after COPD 255 cases | Too few cases | 17.7% | 20% |
| Readmitted after heart bypass surgery 270 cases | Too few cases | 10.2% | 11% |
| Days back in hospital after a heart attack 521 cases | Too few cases | -12.5 days per 100 | — |
| Days back in hospital after heart failure 1,633 cases | Too few cases | 1.3 days per 100 | — |
| Days back in hospital after pneumonia 1,273 cases | Too few cases | 16.6 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 1,020 cases | No different | 11.3 per 1,000 likely 8.6 per 1,000 – 15 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 1,314 cases | Worse | 12.8 per 100 likely 11.1 per 100 – 14.7 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 1,314 cases | No different | 4.7 per 100 likely 3.8 per 100 – 5.9 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 1,648 cases | No different | 1 likely 0.8 – 1.2 | — |
2 more measures had too few cases here to report.
Clinicians registered at this address
1,531 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 156 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Nurse Anesthetist, Certified Registered | 139 |
| Physician Assistant | 106 |
| Pediatrics | 105 |
| Internal Medicine | 101 |
| Family | 79 |
| Emergency Medicine | 78 |
| Anesthesiology | 76 |
| Nurse Practitioner | 66 |
| Surgery | 60 |
| Hospitalist | 59 |
| Obstetrics & Gynecology | 50 |
| Critical Care Medicine | 42 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $8.5M
- 2020 $10.3M
- 2021 $8.2M
- 2022 $6.1M
- 2023 $6.9M
- 2024 $6.9M
- 2025 $7.6M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Consulting fees | $500,400 | 92 |
| Medical devices and supplies on long-term loan | $81,082 | 7 |
| Space rental and facility fees | $67,168 | 22 |
| Speaking, teaching and other services | $34,809 | 14 |
| Grants | $5,500 | 3 |
| Debt forgiveness | $1,990 | 3 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Merck Sharp & Dohme LLC | $2.8M | 47 |
| Abbvie INC. | $554,734 | 54 |
| MIMEDX Group, Inc. | $500,400 | 92 |
| Roche Molecular Systems, INC. | $486,084 | 12 |
| Seagen INC. | $477,119 | 23 |
| Incyte Corporation | $311,381 | 43 |
| Syndax Pharmaceuticals, Inc. | $305,305 | 14 |
| Genentech, Inc. | $241,747 | 19 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Pembrolizumab Versus Placebo as Adjuvant Therapy Following Surgery and Radi… Merck Sharp & Dohme LLC | $648,061 |
| RD005618 ROCHE MOLECULAR SYSTEMS, INC. | $427,935 |
| A Phase 3, Randomized, Double-Blind, Placebo- and Active-Comparator Controlled Clinical study of Adjuvant V940 mRNA-4157 Plus Pembrolizumab Versus Ad… Merck Sharp & Dohme LLC | $381,918 |
| Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unres… ABBVIE INC. · NCT06107413 | $309,337 |
| A PHASE 2 MULTICOHORT OPENLABEL MULTICENTER CLINICAL STUDY EVALUATING THE EFFICACY AND SAFETY OF DISITAMAB VEDOTIN RC48ADC ALONE OR IN COMBINATION WI… SEAGEN INC. | $306,232 |
| A PHASE 1/2 STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS, AND EFFICACY OF SNDX-5613 IN PATIENTS WITH COLORECTAL … Syndax Pharmaceuticals, Inc. | $305,305 |
| Adjuvant Therapy with Pembrolizumab versus Placebo in Resected High Risk Stage II Melanoma# A Randomized, Double-blind Phase III Study KEYNOTE 716 Merck Sharp & Dohme LLC | $280,836 |
| A Multicenter, Open-label, Phase 2 Trial to Assess the Efficacy and Safety of Lenvatinib E7080,MK-7902 in Combination with Pembrolizumab MK-3475 in P… Merck Sharp & Dohme LLC | $245,575 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Inova Fairfax Hospital
Is Inova Fairfax Hospital a good hospital?
Inova Fairfax Hospital has a CMS overall rating of 5 out of 5 stars. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 7 and worse on 2. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Inova Fairfax Hospital?
80% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 877 completed HCAHPS surveys.
How long is the wait in the Inova Fairfax Hospital emergency room?
Emergency patients spend a median of 2 h 41 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 0% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Inova Fairfax Hospital receive money from drug and device companies?
Drug and device makers reported $7.6M in payments to Inova Fairfax Hospital for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.